NEJM's Twitter Profile Analysis @nejm on Twitter
Following information is based on analysis of 200 tweets, from 30/11/2020 to 16/01/2021.
NEJM
@NEJMCorey S. Davis, J.D., M.S.P.H. discusses the recent federal settlement with Purdue Pharma over its actions to increase prescriptions of its opioid medications.
NEJM
@NEJMCovid-19 Rx: Your task is to gather data, develop a differential diagnosis, order additional diagnostic tests, and treat the patient. (Optimized for desktop PCs and most tablets.)
@NEJMGroup #COVID19
NEJM
@NEJMAn 83-year-old man presented with fatigue, weight loss, and postural hypotension. Computed tomography of the abdomen revealed marked enlargement of both adrenal glands, and a diagnosis of primary adrenal lymphoma was made.
NEJM
@NEJMOver the objections of numerous members of Congress, state attorneys general, and families of people killed by opioids, Purdue Pharma and the Sacklers were permitted to enter into plea agreements that resolve all current federal criminal and civil charges against them.
NEJM
@NEJMNow available, the Covid-19 Vaccine Resource Center includes important articles, related resources, and answers to FAQs to provide practical guidance for your practice and patients.
#COVID19 #IDTwitter
NEJM
@NEJMEwing’s sarcoma, an aggressive cancer of bone and soft tissue, primarily affects children and young adults. A t(11;22) translocation is noted in 85 to 90% of cases. Management includes surgery, radiotherapy, and chemotherapy. The 5-year survival is about 70%.
NEJM
@NEJMThe NEJM Race and Medicine topic page features a selection of NEJM articles on race and medicine with implications for improving patient care, professional training, research, and public health. All articles assembled on the page are freely available.
NEJM
@NEJMRecent analyses provide reassurance about using paclitaxel-coated devices in patients with peripheral arterial disease, but the FDA believes that clinical studies of these devices should continue and should collect long-term mortality data.
NEJM
@NEJMIn this audio interview conducted on January 13, 2021, the editors are joined by South African infectious disease physician Salim Abdool Karim to discuss Covid-19 in Africa and the impact of a newly discovered SARS-CoV-2 variant.
#COVID19 #IDTwitter
NEJM
@NEJMA federal “Transparency in Coverage” rule requires insurers to disclose list prices and historical net prices for medications and to give patients personalized cost-sharing estimates. Despite industry opposition, the rule may endure under the Biden administration.
NEJM
@NEJMRemarkable progress in drug development has transformed pulmonary arterial hypertension from a disease that is rapidly fatal into one that in some patients may be managed with pharmacotherapy.
NEJM
@NEJMPatients with pulmonary hypertension due to interstitial lung disease were randomly assigned to inhale treprostinil or placebo. At 16 weeks, there was a significant improvement in exercise capacity with inhaled treprostinil as compared with placebo, assessed by a 6-minute walk.
NEJM
@NEJMRandomized convalescent plasma trials of hospitalized
#COVID19 patients provided weak evidence of clinical efficacy. No unexpected safety signals beyond the recognized risks of plasma transfusion have emerged, nor has there been evidence of antibody-dependent enhancement.
NEJM
@NEJMAmong 3,000 hospitalized patients with
#COVID19, recipients of high-titer convalescent plasma had a lower mortality at 30 days than recipients of low-titer plasma. The effect of high-titer plasma was greatest in the subgroup of patients who were not on mechanical ventilation.